Skip to Main Content

Author Details

Ole Christian Lingj??rde
University of Oslo
1997
100
35
PMIDPaper TitleJournal TitlePublished Year
36861406The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.Haematologica2023
37837931Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.EBioMedicine2023
37683053Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.Leuk Lymphoma2023
34165864Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression.Mol Oncol2022
35381325NRF2 drives an oxidative stress response predictive of breast cancer.Free Radic Biol Med2022
35574381Prognostic Significance of the Loss of Heterozygosity of <i>KRAS</i> in Early-Stage Lung Adenocarcinoma.Front Oncol2022
36923555Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome.Cancer Res Commun2022
36477895Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers.Nucleic Acids Res2022
34036235Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers.JCO Precis Oncol2021
35590201A Systemic Protein Deviation Score Linked to PD-1<sup>+</sup> CD8<sup>+</sup> T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma.Med2021
33566819miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.PLoS Comput Biol2021
34885228Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer.Cancers (Basel)2021
34625038Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.BMC Cancer2021
33961700Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer.Int J Cancer2021
32374878Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series.Blood Adv2020
32580154Frequent copy number gains of SLC2A3 and ETV1 in testicular embryonal carcinomas.Endocr Relat Cancer2020
32208873Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study.Acta Oncol2020
32488909Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.Int J Cancer2020
30692535Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.Nat Commun2019
31704995PathTracer: High-sensitivity detection of differential pathway activity in tumours.Sci Rep2019
31402562miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.Mol Oncol2019
30854794The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.Mol Oncol2019
30962452Breast cancer quantitative proteome and proteogenomic landscape.Nat Commun2019
30846496A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.Haematologica2019
30606786Convergence of risk prediction models in follicular lymphoma.Haematologica2019
29338700Correction to: A systematic comparison of copy number alterations in four types of female cancer.BMC Cancer2018
30080252The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.Br J Haematol2018
30133130Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors.Mol Oncol2018
30076236Reply to Park et al.: Human ectoparasite transmission of plague during the Second Pandemic is still plausible.Proc Natl Acad Sci U S A2018
30497530Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.Genome Med2018
30374075Neutral tumor evolution?Nat Genet2018
30559362Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.Nat Commun2018
29698574N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.Mol Oncol2018
29458389Artesunate shows potent anti-tumor activity in B-cell lymphoma.J Hematol Oncol2018
29217528T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.Clin Cancer Res2018
29339508Human ectoparasites and the spread of plague in Europe during the Second Pandemic.Proc Natl Acad Sci U S A2018
27919819Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency.Clin Immunol2017
28487444The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.Clin Cancer Res2017
28356166Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.Breast Cancer Res2017
29089486Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.Nat Commun2017
28525538chimeraviz: a tool for visualizing chimeric RNA.Bioinformatics2017
28761742Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.ESMO Open2017
28733194Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters.Am J Pathol2017
27341313The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.Br J Haematol2016
26590090Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma.Mol Oncol2016
26261061AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.Pharmacogenomics J2016
27876019A systematic comparison of copy number alterations in four types of female cancer.BMC Cancer2016
27472274Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.PLoS Genet2016
27350877Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes.Cancer Metab2016
27135926Landscape of somatic mutations in 560 breast cancer whole-genome sequences.Nature2016
  • 1 - 50 of 100

Recommended Authors

Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 2
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 8
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 22
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 1
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 4
Gabriela Alexe
Dana-Farber Cancer Institute
Career Start Year 2004
Number of shared co-authors 0
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 11
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 0
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 7
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 4
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 10
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 2
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 8
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 25
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 20
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 12
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Career Start Year 1996
Number of shared co-authors 7
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 4
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 2
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 9
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 4
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 16
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 34

Collaborators

Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 56
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 34
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Co-authored papers 16
Peter Van Loo
The Francis Crick Institute
Co-authored papers 11
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 7
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 7
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 6
Arnoldo Frigessi
University of Oslo
Co-authored papers 5
Eivind Hovig
Center for Bioinformatics, University of Oslo
Co-authored papers 4
Michael R Stratton
Wellcome Sanger Institute
Co-authored papers 4
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 4
Kevin P White
Co-authored papers 3
Ola Myklebost
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 3
Jonas Demeulemeester
VIB-KU Leuven Center for Cancer Biology
Co-authored papers 3
Yves Moreau
KU Leuven - University of Leuven
Co-authored papers 3
Sigve Nakken
University of Oslo
Co-authored papers 3
Vigdis Nygaard
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 2
Giske Ursin
Co-authored papers 2
Kjetil Boye
Oslo University Hospital
Co-authored papers 2
Charles M Perou
Co-authored papers 2
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers 2
Janne Lehti??
Karolinska Institutet
Co-authored papers 2
Moritz Gerstung
German Cancer Research Centre DKFZ
Co-authored papers 2
Inigo Martincorena
Wellcome Sanger Institute
Co-authored papers 2
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 2
Henrik J Johansson
Karolinska Institutet
Co-authored papers 2
Pauline M Rudd
Co-authored papers 2
Oscar M Rueda
University of Cambridge
Co-authored papers 2
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Ingrid K Glad
University of Oslo
Co-authored papers 1
Release 1.2